Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06000670
NCT06000670
Not Yet Recruiting
N/A

Efficacy of Autologous Adipose Derived Stromal Vascular Fraction for Musculoskeletal Conditions

Dubai Health Authority0 sites300 target enrollmentDecember 30, 2026
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsKnee Osteoarthritis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Knee Osteoarthritis
Sponsor
Dubai Health Authority
Enrollment
300
Primary Endpoint
change in pain level
Status
Not Yet Recruiting
Last Updated
8 months ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

clinical efficacy of autologous stromal vascular fraction SVF,for inflammatory and degenerative conditions of the knees

Detailed Description

to evaluate the clinical effectiveness of point of care autologous adipose derived stromal vascular fraction (SVF) alone or in combination with exosomes,for inflammatory and degenerative conditions of the knees.

Registry
clinicaltrials.gov
Start Date
December 30, 2026
End Date
December 1, 2028
Last Updated
8 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amer Mansour

consultant orthopedic surgeon

Dubai Health Authority

Eligibility Criteria

Inclusion Criteria

  • •knee osteoarthritis any grade
  • •knee chondromalacia grade 2 and above

Exclusion Criteria

  • •active HIV
  • •pregnant women
  • •Mental disease
  • •severe cardio vascular disease
  • •severe coagulation disorders
  • •infected tissues
  • •patients on other experimental studies within 3 months

Outcomes

Primary Outcomes

change in pain level

Time Frame: 2 years

visual analog scale 0-10 ( 10 being worst)

Secondary Outcomes

  • percentage cartilage thickness change(2 years)

Similar Trials

Unknown
N/A
Use of Autologous Adipose-Derived Stromal Vascular Fraction To Treat Osteoarthritis of Hip, Knee, Ankle, and Thumb JointsOsteoarthritis
NCT03166410Texas Plastic Surgery500
Recruiting
Phase 1
Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot UlcersDiabetic Foot UlcerDiabetes MellitusDiabetic FootDiabetic Foot InfectionDiabetic Foot Ulcer NeuropathicFoot Ulcer Due to Type 1 Diabetes MellitusFoot Ulcer Due to Type 2 Diabetes MellitusFoot UlcerDiabetes ComplicationsChronic Diabetic Ulcer of Left FootChronic Diabetic Foot Ulcer of Right Foot
NCT05610865University of the Punjab28
Withdrawn
Phase 1
Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic ConditionsMultiple SclerosisAutoimmune
NCT02939859Healeon Medical Inc
Completed
N/A
Adipose-derived SVF for the Treatment of Knee OAOsteoarthritis (OA)
NCT02726945GID BIO, Inc.39
Completed
N/A
Effect of autologous adipose-derived stromal vascular fraction transplantation on endometrial regeneration in patients of Asherman’s syndromePregnancy, childbirth and the puerperium
KCT0003461Bundang CHA General Hospital10